Image-based analysis of lipid nanoparticle–mediated siRNA delivery, intracellular trafficking and endosomal escape
Top Cited Papers
- 23 June 2013
- journal article
- research article
- Published by Springer Nature in Nature Biotechnology
- Vol. 31 (7) , 638-646
Abstract
Delivery of short interfering RNAs (siRNAs) remains a key challenge in the development of RNA interference (RNAi) therapeutics. A better understanding of the mechanisms of siRNA cellular uptake, intracellular transport and endosomal release could critically contribute to the improvement of delivery methods. Here we monitored the uptake of lipid nanoparticles (LNPs) loaded with traceable siRNAs in different cell types in vitro and in mouse liver by quantitative fluorescence imaging and electron microscopy. We found that LNPs enter cells by both constitutive and inducible pathways in a cell type-specific manner using clathrin-mediated endocytosis as well as macropinocytosis. By directly detecting colloidal-gold particles conjugated to siRNAs, we estimated that escape of siRNAs from endosomes into the cytosol occurs at low efficiency (1–2%) and only during a limited window of time when the LNPs reside in a specific compartment sharing early and late endosomal characteristics. Our results provide insights into LNP-mediated siRNA delivery that can guide development of the next generation of delivery systems for RNAi therapeutics.Keywords
This publication has 47 references indexed in Scilit:
- Macropinocytosis of the PDGF β-receptor promotes fibroblast transformation by H-RasG12VMolecular Biology of the Cell, 2012
- Rab5 is necessary for the biogenesis of the endolysosomal system in vivoNature, 2012
- Efficient and targeted delivery of siRNA in vivoThe FEBS Journal, 2010
- A status report on RNAi therapeuticsSilence, 2010
- Enhanced Cytoplasmic Delivery of siRNA Using a Stabilized Polyion Complex Based on PEGylated Nanogels with a Cross-Linked Polyamine StructureBiomacromolecules, 2009
- A large-scale chemical modification screen identifies design rules to generate siRNAs with high activity, high stability and low toxicityNucleic Acids Research, 2009
- Antibody-Mediated Targeting of siRNA via the Human Insulin Receptor Using Avidin−Biotin TechnologyMolecular Pharmaceutics, 2008
- Dynasore, a Cell-Permeable Inhibitor of DynaminDevelopmental Cell, 2006
- Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAsNature, 2004
- The Tetraspanin CD63/lamp3 Cycles between Endocytic and Secretory Compartments in Human Endothelial CellsMolecular Biology of the Cell, 2000